Written by Kevin Wafula
Written by Opondo Herman
Aeras has announced the initiation of a large, multi-country Phase IIb clinical trial , in TB-endemic sub-Saharan African countries, starting in South Africa. The trial is to evaluate the ability of a novel vaccine candidate to prevent tuberculosis disease in adults.
Written by Raymond Gichuki
A candidate Ebola vaccine could be given to healthy volunteers in the UK, The Gambia and Mali as early as September, as part of a series of safety trials of potential vaccines aimed at preventing the disease that has killed more than 1,400 people in the current outbreak in West Africa.
Page 1 of 69